Celltech Group acquires Medeva - MarketLine Financial Deals

Celltech Group acquires Medeva

Celltech Group acquires Medeva - MarketLine Financial Deals
Celltech Group acquires Medeva
Published Jan 24, 2000
2 pages — Published Jan 24, 2000
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

The Chancery Division of the High Court has approved the acquisition of all the outstanding shares of Medeva plc by Celltech Group plc, a biotechnology company. Both the companies are based in the UK.

  
Source:
Document ID
MA76985_110825
Country
Country
Ticker
UCB=BE
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Celltech Group acquires Medeva" Jan 24, 2000. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Celltech-Group-acquires-Medeva-2052-67665>
  
APA:
MarketLine Financial Deals. (2000). Celltech Group acquires Medeva Jan 24, 2000. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Celltech-Group-acquires-Medeva-2052-67665>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.